LAURUS GENERICS INC FDA Approval ANDA 212421

ANDA 212421

LAURUS GENERICS INC

FDA Drug Application

Application #212421

Application Sponsors

ANDA 212421LAURUS GENERICS INC

Marketing Status

None (Tentative Approval)001
None (Tentative Approval)002

Application Products

001TABLET;ORAL10MG0EMPAGLIFLOZINEMPAGLIFLOZIN
002TABLET;ORAL25MG0EMPAGLIFLOZINEMPAGLIFLOZIN

FDA Submissions

UNKNOWN; ORIG1TA2022-06-30STANDARD

Submissions Property Types

ORIG1Null31

CDER Filings

LAURUS GENERICS INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 212421
            [companyName] => LAURUS GENERICS INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"EMPAGLIFLOZIN","activeIngredients":"EMPAGLIFLOZIN","strength":"10MG","dosageForm":"TABLET;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"},{"drugName":"EMPAGLIFLOZIN","activeIngredients":"EMPAGLIFLOZIN","strength":"25MG","dosageForm":"TABLET;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"06\/30\/2022","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-06-30
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.